Population pharmacokinetic analysis of doripenem after intravenous infusion in Korean patients with acute infections
DH Lee, YK Kim, K Jin, MJ Kang, YD Joo… - Antimicrobial agents …, 2017 - Am Soc Microbiol
We investigated the population pharmacokinetics (PK) of doripenem in Korean patients with
acute infections and determined an appropriate dosing regimen using a Monte Carlo …
acute infections and determined an appropriate dosing regimen using a Monte Carlo …
Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic–pharmacodynamic analysis
Y Ohata, Y Tomita, M Nakayama, K Tamura… - Journal of Infection and …, 2011 - Elsevier
The objectives of this study were to develop a population pharmacokinetic (PK) model of
meropenem, to simulate the percent time above minimum inhibitory concentration (% T> …
meropenem, to simulate the percent time above minimum inhibitory concentration (% T> …
Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis
S Kawano, K Matsumoto, R Hara, Y Kuroda… - Journal of Infection and …, 2015 - Elsevier
The pharmacokinetics of meropenem have not yet been examined in Japanese patients
receiving Continuous venovenous hemodialysis (CVVHD). The aim of this clinical …
receiving Continuous venovenous hemodialysis (CVVHD). The aim of this clinical …
Evaluation of the meropenem dosage and administration schedule in patients with bacteremia initial therapy
T Tai, T Yamamoto, K Yamaguchi, M Watanabe… - Journal of Infection and …, 2023 - Elsevier
Background The standard meropenem (MEPM) regimen allowed by insurance in Japan is
0.5 g two or three times a day. Differences in dosages and administration schedules in …
0.5 g two or three times a day. Differences in dosages and administration schedules in …
Plasma pharmacokinetic and heart distribution studies of Z-GP-EPI, a hypocardiotoxic prodrug of epirubicin
G Liu, E Mo, X Wang, N Wu, F Liu, W Yuan… - Tropical Journal of …, 2015 - ajol.info
Purpose: To explore the plasma pharmacokinetics and heart distribution of Z-GP-EPI, a low
cardiotoxic prodrug of epirubicin (EPI). Methods: The drugs were administered to 20 rats (11 …
cardiotoxic prodrug of epirubicin (EPI). Methods: The drugs were administered to 20 rats (11 …
The first report on pharmacokinetic/pharmacodynamic study of trimethoprim/sulfamethoxazole against staphylococcus aureus with a neutropenic murine thigh …
M Hagihara, H Kato, S Uchida, R Yamashita… - Chemotherapy, 2020 - karger.com
Introduction: With an increase in the incidence of Staphylococcus aureus infections in the
healthcare settings and in the community, trimethoprim/sulfamethoxazole (TMP/SMX) has …
healthcare settings and in the community, trimethoprim/sulfamethoxazole (TMP/SMX) has …
Development and assessment of a nomogram to propose the initial dosage regimen of a meropenem infusion based on serum creatinine and age using a Monte …
N Shino, T Uchida, M Yoshida… - Chemical and …, 2015 - jstage.jst.go.jp
A conventional nomogram, based on serum creatinine (sCr) and age, was developed in
order to determine the correct initial dosage regimen for meropenem (MEPM) infusions in …
order to determine the correct initial dosage regimen for meropenem (MEPM) infusions in …
Population Pharmacokinetic Modeling of Unbound Meropenem in Patients Undergoing Continuous Renal Replacement Therapy: An Observational Cohort Study
K Oda, H Jono, H Kamohara… - Therapeutic Drug …, 2022 - journals.lww.com
Background: The most effective dosing strategy of meropenem for patients undergoing
continuous renal replacement therapy (CRRT) remains uncertain. This study aimed to …
continuous renal replacement therapy (CRRT) remains uncertain. This study aimed to …
[PDF][PDF] Population pharmacokinetics of meropenem in Vietnamese adult patients
Meropenem is a broad-spectrum antimicrobial frequently used for serious infections.
Understanding the pharmacokinetics of meropenem is crucial in optimizing the dosage …
Understanding the pharmacokinetics of meropenem is crucial in optimizing the dosage …
Development and evaluation of an optimized dosage regimen for carbapenems in elderly patients based on PK–PD parameters and Monte Carlo simulations
N Shino, T Uchida, M Yoshida… - The Japanese Journal of …, 2015 - jstage.jst.go.jp
A conventional nomogram, based on creatinine clearance (CCR), was developed to provide
an individualized, optimized, dosage regimen for the carbapenem antibacterial agents …
an individualized, optimized, dosage regimen for the carbapenem antibacterial agents …